Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment Monitoring of Advanced Colorectal Cancer with PET
2008-001499-55Phase 4Completed
- Sponsor
- Turku PET Centre
- Start
- Mar 2008
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of irinotecan, oxaliplatin, fluorouracil and cetuximab in colorectal cancer (CRC), sponsored by Turku PET Centre. Started Mar 2008; status: completed.
02
Drugs
irinotecanoxaliplatinfluorouracilcetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2008-001499-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001499-55.